psoriasis: Studies of biologics for treatment of moderate-to-severe...

Description Usage Format References


A dataset from a systematic review of Randomised-Controlled Trials (RCTs) comparing biologics at different doses and placebo \insertCitewarren2019MBNMAdose. Three different binary outcomes are included, all based on the number of patients experiencing degrees of improvement on the Psoriasis Area and Severity Index (PASI) measured at 12 weeks follow-up. The dataset includes 28 Randomised-Controlled Trials (RCTs), comparing 9 different biologics at different doses with placebo.




A data frame in long format (one row per arm and study), with 81 rows and 9 variables:


MBNMAdose documentation built on Sept. 13, 2020, 5:08 p.m.